Arrowhead Research Corporation News Headlines

ARWR 
$7.53
*  
0.21
2.71%
Get ARWR Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading ARWR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ARWR Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
GoPro Is A Football Stock - Cramer's Lightning Round (2/26/15)
2/27/2015 6:39:00 AM - Seeking Alpha


4 Biotech Stocks Under $10 to Trade for Breakouts: Sophiris, Atossa and More
2/17/2015 1:20:00 PM - TheStreet


Earnings Reported After The Bell Feb. 9
2/10/2015 2:26:00 AM - RTT News


Earnings Peek: Arrowhead Research Corporation's Focus Is On The Clinical Hold
2/4/2015 9:42:00 AM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Roche Takes Control, Shire's A Buyer, And More
1/16/2015 4:00:00 PM - Seeking Alpha


Tekmira/Oncore Merger Represents Substantial Upside
1/12/2015 8:49:00 AM - Seeking Alpha


Arrowhead Reports Partial Clinical Hold For ARC-50 Phase 2b Study - Quick Facts
1/12/2015 7:23:00 AM - RTT News


Assessing Gilead's Reality-Perception Gap: Upside Revenue Surprise
1/6/2015 2:32:00 PM - Seeking Alpha


Marina Biotech: A Forgotten And Grossly Undervalued Game Changer
11/25/2014 11:40:00 AM - Seeking Alpha


Marina Biotech: A Forgotten And Grossly Undervalued Game-Changer
11/25/2014 10:30:00 AM - Seeking Alpha


Arrowhead explains the ARC-520 data
10/9/2014 9:18:00 AM - Seeking Alpha


If Gilead's Hepatitis C Treatment Grosses $10B+ Per Year, Arrowhead's Hepatitis B Treatment Is Attractive.
10/6/2014 11:57:00 AM - Seeking Alpha


Ocera Therapeutics Finally Ready To Reward Investors
10/1/2014 12:32:00 PM - Seeking Alpha


Cramer's Mad Money - 2 Biotech Takeover Targets (9/11/14)
9/12/2014 5:47:00 AM - Seeking Alpha


Incyte Pharmaceutical: Top Idea For 2H14 With 2 Free Call Options Driving M&A Valuation To $93, Gilead Most Likely Suitor
9/11/2014 10:49:00 AM - Seeking Alpha


Cramer's Lightning Round - I'm Not Touching Potbelly (8/13/14)
8/14/2014 6:25:00 AM - Seeking Alpha


Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
8/12/2014 2:06:00 PM - Investopedia


Arrowhead's Hep B Phase 2a Topline Data Imminent - 'Transformational' Potential
8/12/2014 12:27:00 PM - Seeking Alpha


Has The Tekmira Pharmaceuticals Ebola Trade Run Its Course?
8/5/2014 11:54:00 AM - Seeking Alpha


Alnylam And Benitec
7/25/2014 8:16:00 AM - Seeking Alpha


Tekmira Pharmaceuticals: Is The Clinical Hold Sell-Off A Buying Opportunity?
7/22/2014 9:50:00 AM - Seeking Alpha


Tiger Soup
4/29/2014 9:22:00 AM - Seeking Alpha


Arrowhead: A Functional Cure For The Hepatitis B Virus
2/19/2014 9:14:00 AM - Seeking Alpha


SA PRO: Top Long And Short Ideas, Friday February 7
2/8/2014 7:30:00 AM - Seeking Alpha


Arrowhead: There Is Still Plenty Of Room For Share Price Appreciation
2/7/2014 8:51:00 AM - Seeking Alpha